60
Participants
Start Date
February 2, 2023
Primary Completion Date
July 31, 2025
Study Completion Date
July 31, 2025
Rifaximin
Rifaximin oral tablet, 550 mg, twice daily, two-weeks
Placebo
Placebo oral tablet, twice daily, two-weeks
RECRUITING
UZ/KU Leuven, Leuven
Universitaire Ziekenhuizen KU Leuven
OTHER